What kind of targeted drug is Selinisol? What will happen if you eat it?

Selinexor (Selinexor) is an orally bioavailable, selective nuclear export inhibitor compound that inhibits exportin 1 (XPO1), a novel therapeutic target overexpressed in multiple myeloma (MM) that is responsible for the transport of 220 nuclear proteins into the cytoplasm, including tumor suppressor proteins. Inhibition of this process has demonstrated significant antimyeloma activity in preclinical studies, either alone or in combination with established multiple myeloma therapies.

Specific reactions to selinexol vary from person to person, as does everyone's physical condition and tolerance to the drug. The main purpose of the drug is to treat tumors. In some patients, selinesol may cause tumor shrinkage or control tumor growth. However, tumor responses to drugs are complex, and not all patients will have the same effect. Because of selinesol's effects on blood cells, patients may need periodic blood tests to monitor their blood cell counts. This helps any potential issues be identified and dealt with promptly. Like many drugs, selinexol may cause some side effects. This may include nausea, vomiting, fatigue, loss of appetite, low platelet count, low white blood cell count, etc. The severity and frequency of these side effects vary from individual to individual.

Seleniso is a prescription medication and should be used under the supervision of a doctor. Doctors will assess the patient's overall health before administering medication and develop a personalized treatment plan based on the specific situation. During treatment with selinesol, patients should pay close attention to their body's reactions and promptly report any discomfort or abnormal symptoms to their doctor. The doctor will adjust the dose, treatment plan or provide corresponding supportive treatment based on the patient's response.